Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9827295

Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a re

Regents of the University of Minnesota · Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9827327

Methods and compositions related to adenoassociated virus-phage particles

The Board of Regents of the University of Texas System · Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9820970

Method and agent for the treatment and prophylaxis of diseases caused by (+)RNA-containing

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9822162

Anti-human papillomavirus 16 E6 T cell receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9821049

Method of conferring a protective immune response to Norovirus

Takeda Vaccines, Inc. · Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9815887

Monoclonal antibodies that neutralize a norovirus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9814771

Live attenuated classical swine fever vaccine based in genetic manipulation of a putative

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9809643

Identification of antibodies specific for at least two different lyssaviruses

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9808520

Rationally developed african swine fever attenuated virus strain protects against challeng

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9808459

Inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9801934

Parenteral norovirus vaccine formulations

Takeda Vaccines, Inc. · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9802949

Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9795665

Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9790473

Human Ebola virus species and compositions and methods thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9783788

Porcine pseudorabies virus (PRV)-YF strain and its application

SOUTH CHINA AGRICULTURAL UNIVERSITY · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9783787

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of den

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9783596

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephal

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9783579

Compositions and methods for dengue virus chimeric constructs in vaccines

granted patent

US 9777340

Compositions and methods for detecting human Pegivirus 2 (HPgV-2)

The Regents of the University of California · Granted Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9771361

Inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9771414

Human antibodies to ebola virus glycoprotein

REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9770427

Antiviral treatments

BioCryst Pharmaceuticals, Inc. · Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9764022

Methods and compositions for inhibiting polyomavirus-associated pathology

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9757407

Treatment of viral infections by modulation of host cell metabolic pathways

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted